Pharvaris
4 known investors
Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema. It is a clinical-stage biopharmaceutical company focused on this rare disease area.
BiotechHealthtech
Investors Β· 4
Frequently asked questions
- What does Pharvaris do?
- Pharvaris develops investigational oral therapies for people living with bradykinin-mediated angioedema. It is a clinical-stage biopharmaceutical company focused on this rare disease area.
- Who are Pharvaris's investors?
- Pharvaris's investors include Bain Capital Life Sciences, Foresite Capital, Kurma Partners, venBio Partners.